Dilution of equity value resulting from the exercise of stock acquisition rights
First written in FY2020. 10 of 16 entries say "Materialised", first in FY2021-Q1. Latest entry: 2026-08-14.
Speee moved to the "Worse" side of this theme in 2021, 1 year after the typical company in this theme (2020).
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
32 other companies' latest entry also says "Worsened".
- 2026-08-14WorsenedRevision of earnings forecasts
「Diluted quarterly net income per share has not been presented because, although potential shares exist, the Company recorded a quarterly net loss per share.」
The disclosure changed from stating that no potential shares existed in FY2025-H1 to stating that potential shares exist. - FY2025-H1MitigatedAnnual report
「① [Terms of the stock-option program] Not applicable. ② [Status of other share acquisition rights] Not applicable.」
The interim-period share information states that no stock option plan or other stock acquisition rights apply, and the note on diluted earnings per share also states that there are no potential shares. - FY2024-Q1MaterialisedAnnual report
「1 October 2023–31 December 2023 (Note) 153,950 10,619,950 6,465 1,430,417 6,465 1,420,427 / (Note) These changes resulted from the exercise of stock acquisition rights.」
153,950 shares were issued through the exercise of stock acquisition rights during the first quarter, bringing the total number of issued shares to 10,619,950. - FY2023MitigatedAnnual report
「As of 30 September 2023, the number of potential shares represented by stock acquisition rights was 243,797, equivalent to 2.3% of the total number of issued shares of 10,466,000.」
Although 196,950 shares were issued through the exercise of the fifth series of stock acquisition rights during FY2023, the ratio of potential shares at fiscal year-end fell from 4.5% in FY2022 to 2.3%. Stock acquisition rights that may cause dilution remain outstanding. - FY2023-Q3MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note) 79,650 10,466,000 3,345 1,423,951 3,345 1,413,961 / (Note) These changes resulted from the exercise of stock acquisition rights.」
79,650 shares were issued through the exercise of stock acquisition rights during the third quarter, bringing the total number of issued shares to 10,466,000. Events potentially causing dilution continued to occur in practice. - FY2023-Q2MaterialisedAnnual report
「1 February 2023–28 February 2023 (Note) 2. 6,600 10,349,100 277 1,389,949 277 1,379,959」
6,600 shares were issued through the exercise of stock acquisition rights during the second quarter of FY2023, increasing the total number of issued shares. The issuance of a further 1,600 shares in April 2023 as of the filing date is also recorded. - FY2023-Q1MaterialisedAnnual report
「1 October 2022–31 December 2022 (Note) 1. 110,700 10,332,500 4,649 1,381,442 4,649 1,371,452 / (Note) 1. These changes resulted from the exercise of stock acquisition rights.」
110,700 shares were issued through the exercise of stock acquisition rights during the first quarter of FY2023, bringing the total number of issued shares to 10,332,500. Events potentially causing dilution continued to occur in practice. - FY2022MitigatedAnnual report
「As of 30 September 2022, the number of potential shares represented by stock acquisition rights was 579,550, equivalent to 4.5% of the total number of issued shares of 10,221,800.」
Although 124,300 shares were issued through the exercise of stock acquisition rights during FY2022, the ratio of potential shares to total issued shares fell from 5.8% in FY2021 to 4.5%. - FY2022-Q3MaterialisedAnnual report
「1 April 2022–30 June 2022 (Note) 2,650 10,221,000 111 1,376,759 111 1,366,769 / (Note) These changes resulted from the exercise of stock acquisition rights.」
2,650 shares were issued through the exercise of stock acquisition rights during the third quarter, bringing the total number of issued shares to 10,221,000. Events potentially causing dilution continued to occur. - FY2022-Q2MaterialisedAnnual report
「1 January 2022–31 March 2022 (Note) 120,450 10,218,350 5,058 1,376,648 5,058 1,366,658 / (Note) These changes resulted from the exercise of stock acquisition rights.」
From January to March 2022, 120,450 shares were issued through the exercise of stock acquisition rights, bringing the total number of issued shares to 10,218,350. Events potentially causing dilution continued to occur in practice. - FY2022-Q1MaterialisedAnnual report
「1 October 2021–31 December 2021 (Note) 1. 400 10,097,900 16 1,371,589 16 1,361,599 / From 1 January 2022 to 31 January 2022, the exercise of stock acquisition rights increased the total number of issued shares by 119,650 and increased capital and the capital reserve by ¥5,025 thousand each.」
400 shares were issued through the exercise of stock acquisition rights during the first quarter, and a further 119,650 shares were issued in January 2022 before the filing date. Events potentially causing dilution continued to occur. - FY2021MitigatedAnnual report
「As of 30 September 2021, the number of potential shares represented by stock acquisition rights was 584,400, equivalent to 5.8% of the total number of issued shares of 10,097,500.」
The ratio of potential shares fell from 7.9% in FY2020 to 5.8%. Meanwhile, 195,600 shares were issued through the exercise of stock acquisition rights during FY2021, so the risk of dilution itself remains. - FY2021-Q3MaterialisedAnnual report
「1 April 2021–30 June 2021 (Note) 1. 400 10,095,750 16 1,371,498 16 1,361,508 / From 1 July 2021 to 31 July 2021, the exercise of stock acquisition rights increased the total number of issued shares by 850 and increased capital and the capital reserve by ¥35 thousand each.」
The company records an increase of 400 issued shares through the exercise of stock acquisition rights during the third quarter and a further increase of 850 shares in July before the filing date. - FY2021-Q2MaterialisedAnnual report
「1 January 2021–31 March 2021 (Note) 1. 143,450 10,095,350 6,024 1,371,482 6,024 1,361,492 / From 1 April 2021 to 30 April 2021, the exercise of stock acquisition rights increased the total number of issued shares by 350 and increased capital and the capital reserve by ¥14 thousand each.」
The company records an increase of 143,450 issued shares through the exercise of stock acquisition rights from January to March 2021 and a further increase of 350 shares in April, indicating that events potentially causing dilution continued to occur in practice. - FY2021-Q1MaterialisedAnnual report
「From 1 January 2021 to 31 January 2021, the exercise of stock acquisition rights increased the total number of issued shares by 137,600 and increased capital and the capital reserve by ¥5,779 thousand each.」
The company states that shares were actually issued through the exercise of stock acquisition rights, increasing the number of shares. - FY2020First statedAnnual report
「As of 30 September 2020, the number of potential shares represented by stock acquisition rights was 780,000, equivalent to 7.9% of the total number of issued shares of 9,901,900.」
The company states that the exercise of stock acquisition rights granted to officers and employees may dilute the equity value per share and affect the share price.